|
| 泽璟制药-U(688266)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-01-23 | 9660.69 | 40.25% | 24000.00 | 0.00 | 14339.31 | 59.75% | 追加承诺限售股份上市流通 | | 2023-10-23 | 2448.98 | 9.26% | 16788.29 | 9660.69 | 14339.31 | 54.21% | 定向增发机构配售股份 | | 2023-07-25 | 21.84 | 0.08% | 14361.15 | 12109.67 | 14361.15 | 54.25% | 股权激励一般股份 | | 2023-01-30 | 267.48 | 1.11% | 14339.31 | 9660.69 | 14339.31 | 59.75% | 首发原股东限售股份 | | 2022-02-23 | 588.51 | 2.45% | 14071.83 | 9928.17 | 13483.32 | 56.18% | 首发原股东限售股份 | | 2022-01-24 | 180.00 | 0.75% | 13483.32 | 10516.68 | 13483.32 | 56.18% | 首发战略配售股份 |
|